In December 2024, our Central Research Institute successfully filed a patent (Korean Patent Application No. 10-2024-0197191) 

to overcome existing international patents on exosome production methods and secure proprietary technology for the most stable, 

cost-effective, and scalable production of exosome products derived from natural materials and animal-based sources, such as stem cells.

**Notes:**

- Currently, three methods for producing exosomes are internationally patented.  

- International patents (PCT) and individual country filings are being handled in accordance with international agreements.